Andrew Satlin, EVP and Chief Medical Officer at Intra-Cellular Therapies, Inc. (ITCI), sold 23,146 shares at $26.16 ($605K) on 2020-01-09, disclosed to the SEC on 2020-01-10.
Open-market sale of $605k ITCI by EVP and Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.16 | 11,573 | $303K | 50.0% |
| 2 | $26.16 | 11,573 | $303K | 50.0% |
| Total | $26.16 avg | 23,146 | $605K | 100% |